Part 9: Acute coronary syndromes: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care

Circulation

Volumn 132, Issue 18, 2015, Pages S483-S500

  O'Connor, Robert E ^a   Al Ali, Abdulaziz S ^a   Brady, William J ^a   Ghaemmaghami, Chris A ^a   Menon, Venu ^a   Welsford, Michelle ^a   Shuster, Michael ^a  

^a NONE

Author keywords

Electrocardiogram; Fibrinolytics; Myocardial infarction; ST segment elevation; Unstable angina

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; TROPONIN; ADENOSINE DIPHOSPHATE; BIOLOGICAL MARKER;

ACUTE CORONARY SYNDROME; ANTICOAGULATION; ARTICLE; DIAGNOSTIC TEST ACCURACY STUDY; ELECTROCARDIOGRAM; EMERGENCY CARE; FIBRINOLYSIS; FIBRINOLYTIC THERAPY; HUMAN; MEDICAL SOCIETY; OBSERVATIONAL STUDY; OXYGEN DESATURATION; OXYGEN THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; RETURN OF SPONTANEOUS CIRCULATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; ADULT; ANGIOCARDIOGRAPHY; BLOOD; COMPUTER ASSISTED DIAGNOSIS; CONSENSUS DEVELOPMENT; ELECTROCARDIOGRAPHY; EMERGENCY HEALTH SERVICE; HEART MUSCLE REPERFUSION; HEART MUSCLE REVASCULARIZATION; PATIENT TRANSPORT; PROCEDURES; SENSITIVITY AND SPECIFICITY; STANDARDS;

ACUTE CORONARY SYNDROME; ADENOSINE DIPHOSPHATE; ADULT; BIOMARKERS; CORONARY ANGIOGRAPHY; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; EMERGENCY MEDICAL SERVICES; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL REPERFUSION; MYOCARDIAL REVASCULARIZATION; OXYGEN INHALATION THERAPY; PATIENT TRANSFER; SENSITIVITY AND SPECIFICITY; TROPONIN;

EID: 84945266465     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000000263     Document Type: Article

References (118)

1. Bossaert L, O'Connor RE, Arntz HR, Brooks SC, Diercks D, Feitosa-Filho G, Nolan JP, Hoek TL, Walters DL, Wong A, Welsford M, Woolfrey K; Acute Coronary Syndrome Chapter Collaborators. Part 9: acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation. 2010;81 suppl 1:e175-e212. doi: 10.1016/j.resuscitation.2010.09.001.
2. O'Connor RE, Bossaert L, Arntz HR, Brooks SC, Diercks D, Feitosa-Filho G, Nolan JP, Vanden Hoek TL, Walters DL, Wong A, Welsford M, Woolfrey K; Acute Coronary Syndrome Chapter Collaborators. Part 9: acute coronary syndromes: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2010;122(suppl 2):S422-S465. doi: 10.1161/CIRCULATIONAHA.110.985549.
3. Nikolaou NI, Welsford M, Beygui F, Bossaert L, Ghaemmaghami C, Nonogi H, O'Connor RE, Pichel DR, Scott T, Walters DL, Woolfrey KGH; on behalf of the Acute Coronary Syndrome Chapter Collaborators. Part 5: acute coronary syndromes: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Resuscitation. 2015. In press.
4. Welsford M, Nikolaou NI, Beygui F, Bossaert L, Ghaemmaghami C, Nonogi H, O'Connor RE, Pichel DR, Scott T, Walters DL, Woolfrey KGH; on behalf of the Acute Coronary Syndrome Chapter Collaborators. Part 5: acute coronary syndromes: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. Circulation. 2015;132(suppl 1):S146-S176. doi: 10.1161/CIR.0000000000000274.
5. O'Connor D, Higgins JPT, Green S, eds. Chapter 5: Defning the review questions and developing criteria for including studies. In: The Cochrane Collaboration. Higgins JPT, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. 2011. http://handbook. cochrane.org/. Accessed May 6, 2015.
6. Schünemann H, Brozek J, Guyatt G, Oxman A. GRADE Handbook. 2013. http://www.guidelinedevelopment.org/handbook/. Accessed May 6, 2015.
7. O'Connor RE, Brady W, Brooks SC, Diercks D, Egan J, Ghaemmaghami C, Menon V, O'Neil BJ, Travers AH, Yannopoulos D. Part 10: acute coronary syndromes: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122(suppl 3):S787-S817. doi: 10.1161/CIRCULATIONAHA.110.971028.
8. Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ. 2014 ACC/AHA guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:e344-e426. doi: 10.1161/CIR.0000000000000134.
9. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61:e78-e140.
10. O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:e362-e425. doi: 10.1161/CIR.0b013e3182742cf6.
11. Davis M, Lewell M, McLeod S, Dukelow A. A prospective evaluation of the utility of the prehospital 12-lead electrocardiogram to change patient management in the emergency department. Prehosp Emerg Care. 2014;18:9-14. doi: 10.3109/10903127.2013.825350.
12. Le May MR, Dionne R, Maloney J, Trickett J, Watpool I, Ruest M, Stiell I, Ryan S, Davies RF. Diagnostic performance and potential clinical impact of advanced care paramedic interpretation of ST-segment elevation myo-cardial infarction in the feld. CJEM. 2006;8:401-407.
13. Nam J, Caners K, Bowen JM, Welsford M, O'Reilly D. Systematic review and meta-analysis of the benefts of out-of-hospital 12-lead ECG and advance notifcation in ST-segment elevation myocardial infarction patients. Ann Emerg Med. 2014;64:176-86, 186.e1. doi: 10.1016/j. annemergmed.2013.11.016.
14. Bhalla MC, Mencl F, Gist MA, Wilber S, Zalewski J. Prehospital elec-trocardiographic computer identifcation of ST-segment elevation myocardial infarction. Prehosp Emerg Care. 2013;17:211-216. doi: 10.3109/10903127.2012.722176.
15. Clark EN, Sejersten M, Clemmensen P, Macfarlane PW. Automated electrocardiogram interpretation programs versus cardiologists' triage decision making based on teletransmitted data in patients with suspected acute coronary syndrome. Am J Cardiol. 2010;106:1696-1702. doi: 10.1016/j. amjcard.2010.07.047.
16. de Champlain F, Boothroyd LJ, Vadeboncoeur A, Huynh T, Nguyen V, Eisenberg MJ, Joseph L, Boivin JF, Segal E. Computerized interpretation of the prehospital electrocardiogram: predictive value for ST segment elevation myocardial infarction and impact on on-scene time. CJEM. 2014;16:94-105.
17. Squire BT, Tamayo-Sarver JH, Rashi P, Koenig W, Niemann JT. Effect of prehospital cardiac catheterization lab activation on door-to-balloon time, mortality, and false-positive activation. Prehosp Emerg Care. 2014;18:1-8. doi: 10.3109/10903127.2013.836263.
18. Youngquist ST, Shah AP, Niemann JT, Kaji AH, French WJ. A comparison of door-to-balloon times and false-positive activations between emergency department and out-of-hospital activation of the coronary catheterization team. Acad Emerg Med. 2008;15:784-787. doi: 10.1111/j.1553-2712.2008.00186.x.
19. Brown JP, Mahmud E, Dunford JV, Ben-Yehuda O. Effect of prehospi-tal 12-lead electrocardiogram on activation of the cardiac catheteriza-tion laboratory and door-to-balloon time in ST-segment elevation acute myocardial infarction. Am J Cardiol. 2008;101:158-161. doi: 10.1016/j. amjcard.2007.07.082.
20. van 't Hof AW, Rasoul S, van de Wetering H, Ernst N, Suryapranata H, Hoorntje JC, Dambrink JH, Gosselink M, Zijlstra F, Ottervanger JP, de Boer MJ; On-TIME study group. Feasibility and beneft of prehospital diagnosis, triage, and therapy by paramedics only in patients who are candidates for primary angioplasty for acute myocardial infarction. Am Heart J. 2006; 151:1255.e1-1255.e5. doi: 10.1016/j.ahj.2006.03.014.
21. Feldman JA, Brinsfeld K, Bernard S, White D, Maciejko T. Real-time paramedic compared with blinded physician identifcation of ST-segment elevation myocardial infarction: results of an observational study. Am J Emerg Med. 2005;23:443-448.
22. Ducas RA, Wassef AW, Jassal DS, Weldon E, Schmidt C, Grierson R, Tam JW. To transmit or not to transmit: how good are emergency medical personnel in detecting STEMI in patients with chest pain? Can J Cardiol. 2012;28:432-437. doi: 10.1016/j.cjca.2012.04.008.
23. Trivedi K, Schuur JD, Cone DC. Can paramedics read ST-segment elevation myocardial infarction on prehospital 12-lead electrocardiograms? Prehosp Emerg Care. 2009;13:207-214. doi: 10.1080/10903120802706153.
24. Davis DP, Graydon C, Stein R, Wilson S, Buesch B, Berthiaume S, Lee DM, Rivas J, Vilke GM, Leahy DR. The positive predictive value of paramedic versus emergency physician interpretation of the prehospital 12-lead electrocardiogram. Prehosp Emerg Care. 2007;11:399-402. doi: 10.1080/10903120701536784.
25. Lee CH, Van Gelder CM, Cone DC. Early cardiac catheterization laboratory activation by paramedics for patients with ST-segment elevation myocardial infarction on prehospital 12-lead electrocardiograms. Prehosp Emerg Care. 2010;14:153-158. doi: 10.3109/10903120903537213.
26. Young DR, Murinson M, Wilson C, Hammond B, Welch M, Block V, Booth S, Tedder W, Dolby K, Roh J, Beaton R, Edmunds J, Young M, Rice V, Somers C, Edwards R, Maynard C, Wagner GS. Paramedics as decision makers on the activation of the catheterization laboratory in the presence of acute ST-elevation myocardial infarction. J Electrocardiol. 2011;44:18-22. doi: 10.1016/j.jelectrocard.2010.06.010.
27. Dorsch MF, Greenwood JP, Priestley C, Somers K, Hague C, Blaxill JM, Wheatcroft SB, Mackintosh AF, McLenachan JM, Blackman DJ. Direct ambulance admission to the cardiac catheterization laboratory signifcantly reduces door-to-balloon times in primary percutaneous coronary intervention. Am Heart J. 2008;155:1054-1058. doi: 10.1016/j.ahj.2008.01.014.
28. Strauss DG, Sprague PQ, Underhill K, Maynard C, Adams GL, Kessenich A, Sketch MH Jr, Berger PB, Marcozzi D, Granger CB, Wagner GS. Paramedic transtelephonic communication to cardiologist of clinical and electrocardiographic assessment for rapid reperfusion of ST-elevation myocardial infarction. J Electrocardiol. 2007;40:265-270. doi: 10.1016/j. jelectrocard.2006.11.006.
29. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD; the Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Defnition of Myocardial Infarction. Third universal defnition of myocardial infarction. Circulation. 2012;126:2020-2035. doi: 10.1161/CIR.0b013e31826e1058.
30. Mahajan VS, Jarolim P. How to interpret elevated cardiac tro-ponin levels. Circulation. 2011;124:2350-2354. doi: 10.1161/CIRCULATIONAHA.111.023697.
31. Pitts SR, Niska RW, Xu J, Burt CW. National Hospital Ambulatory Medical Care Survey: 2006 emergency department summary. Natl Health Stat Report. 2008:1-38.
32. Aldous SJ, Richards AM, Cullen L, Than MP. Early dynamic change in high-sensitivity cardiac troponin T in the investigation of acute myocardial infarction. Clin Chem. 2011;57:1154-1160. doi: 10.1373/clinchem.2010.161166.
33. Parsonage WA, Greenslade JH, Hammett CJ, Lamanna A, Tate JR, Ungerer JP, Chu K, Than M, Brown AF, Cullen L. Validation of an accelerated high-sensitivity troponin T assay protocol in an Australian cohort with chest pain. Med J Aust. 2014;200:161-165.
34. Cullen L, Mueller C, Parsonage WA, Wildi K, Greenslade JH, Twerenbold R, Aldous S, Meller B, Tate JR, Reichlin T, Hammett CJ, Zellweger C, Ungerer JP, Rubini Gimenez M, Troughton R, Murray K, Brown AF, Mueller M, George P, Mosimann T, Flaws DF, Reiter M, Lamanna A, Haaf P, Pemberton CJ, Richards AM, Chu K, Reid CM, Peacock WF, Jaffe AS, Florkowski C, Deely JM, Than M. Validation of high-sensitivity troponin I in a 2-hour diagnostic strategy to assess 30-day outcomes in emergency department patients with possible acute coronary syndrome. J Am Coll Cardiol. 2013;62:1242-1249. doi: 10.1016/j.jacc.2013.02.078.
35. Kelly AM, Klim S. Prospective external validation of an accelerated (2-h) acute coronary syndrome rule-out process using a contemporary troponin assay. Int J Emerg Med. 2014;7:42. doi: 10.1186/s12245-014-0042-3.
36. Cullen L, Greenslade JH, Than M, Brown AF, Hammett CJ, Lamanna A, Flaws DF, Chu K, Fowles LF, Parsonage WA. The new Vancouver Chest Pain Rule using troponin as the only biomarker: an external validation study. Am J Emerg Med. 2014;32:129-134. doi: 10.1016/j. ajem.2013.10.021.
37. Hess EP, Brison RJ, Perry JJ, Calder LA, Thiruganasambandamoorthy V, Agarwal D, Sadosty AT, Silvilotti ML, Jaffe AS, Montori VM, Wells GA, Stiell IG. Development of a clinical prediction rule for 30-day cardiac events in emergency department patients with chest pain and possible acute coronary syndrome. Ann Emerg Med. 2012;59:115-25.e1. doi: 10.1016/j.annemergmed.2011.07.026.
38. Mahler SA, Miller CD, Hollander JE, Nagurney JT, Birkhahn R, Singer AJ, Shapiro NI, Glynn T, Nowak R, Safdar B, Peberdy M, Counselman FL, Chandra A, Kosowsky J, Neuenschwander J, Schrock JW, Plantholt S, Diercks DB, Peacock WF. Identifying patients for early discharge: performance of decision rules among patients with acute chest pain. Int J Cardiol. 2013;168:795-802. doi: 10.1016/j.ijcard.2012.10.010.
39. Xavier Scheuermeyer F, Wong H, Yu E, Boychuk B, Innes G, Grafstein E, Gin K, Christenson J. Development and validation of a prediction rule for early discharge of low-risk emergency department patients with potential ischemic chest pain. CJEM. 2014;16:106-119.
40. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, Antman EM; TRITON-TIMI 38 investigators. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009;373:723-731. doi: 10.1016/S0140-6736(09)60441-4.
41. Steg PG, James S, Harrington RA, Ardissino D, Becker RC, Cannon CP, Emanuelsson H, Finkelstein A, Husted S, Katus H, Kilhamn J, Olofsson S, Storey RF, Weaver WD, Wallentin L; PLATO Study Group. Ticagrelor versus clopidogrel in patients with ST-elevation acute coronary syndromes intended for reperfusion with primary percutaneous coronary intervention: A Platelet Inhibition and Patient Outcomes (PLATO) trial subgroup analysis. Circulation. 2010;122:2131-2141. doi: 10.1161/CIRCULATIONAHA.109.927582.
42. Zeymer U, Arntz HR, Mark B, Fichtlscherer S, Werner G, Schöller R, Zahn R, Diller F, Darius H, Dill T, Huber K. Effcacy and safety of a high loading dose of clopidogrel administered prehospitally to improve primary percutaneous coronary intervention in acute myocardial infarction: the randomized CIPAMI trial. Clin Res Cardiol. 2012;101:305-312. doi: 10.1007/s00392-011-0393-1.
43. Ducci K, Grotti S, Falsini G, Angioli P, Liistro F, Mandò M, Porto I, Bolognese L. Comparison of pre-hospital 600 mg or 900 mg vs. peri-inter-ventional 300 mg clopidogrel in patients with ST-elevation myocardial infarction undergoing primary coronary angioplasty. The Load&Go randomized trial. Int J Cardiol. 2013;168:4814-4816. doi: 10.1016/j. ijcard.2013.07.012.
44. Montalescot G, van 't Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Stibbe O, Ecollan P, Heutz WM, Swahn E, Collet JP, Willems FF, Baradat C, Licour M, Tsatsaris A, Vicaut E, Hamm CW; ATLANTIC Investigators. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med. 2014;371:1016-1027. doi: 10.1056/NEJMoa1407024.
45. Zijlstra F, Ernst N, de Boer MJ, Nibbering E, Suryapranata H, Hoorntje JC, Dambrink JH, van 't Hof AW, Verheugt FW. Infuence of prehospi-tal administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute ST elevation myocardial infarction. J Am Coll Cardiol. 2002;39:1733-1737.
46. Steg PG, vant Hof A, Hamm CW, Clemmensen P, Lapostolle F, Coste P, Ten Berg J, Van Grunsven P, Eggink GJ, Nibbe L, Zeymer U, Campo dell' Orto M, Nef H, Steinmetz J, Soulat L, Huber K, Deliargyris EN, Bernstein D, Schuette D, Prats J, Clayton T, Pocock S, Hamon M, Goldstein P; EUROMAX Investigators. Bivalirudin started during emergency transport for primary PCI. N Engl J Med. 2013;369:2207-2217. doi: 10.1056/NEJMoa1311096.
47. Sejersten M, Nielsen SL, Engstrøm T, Jørgensen E, Clemmensen P. Feasibility and safety of prehospital administration of bivalirudin in patients with ST-elevation myocardial infarction. Am J Cardiol. 2009;103:1635-1640. doi: 10.1016/j.amjcard.2009.02.015.
48. Bangalore S, Toklu B, Kotwal A, Volodarskiy A, Sharma S, Kirtane AJ, Feit F. Anticoagulant therapy during primary percutaneous coronary intervention for acute myocardial infarction: a meta-analysis of randomized trials in the era of stents and P2Y12 inhibitors. BMJ. 2014;349:g6419.
49. Cavender MA, Sabatine MS. Bivalirudin versus heparin in patients planned for percutaneous coronary intervention: a meta-analysis of randomised controlled trials. Lancet. 2014;384:599-606. doi: 10.1016/S0140-6736(14)61216-2.
50. Stone GW, Mehran R, Goldstein P, Witzenbichler B, Van't Hof A, Guagliumi G, Hamm CW, Généreux P, Clemmensen P, Pocock SJ, Gersh BJ, Bernstein D, Deliargyris EN, Steg PG. Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials. J Am Coll Cardiol. 2015;65:27-38. doi: 10.1016/j.jacc.2014.10.029.
51. Montalescot G, Zeymer U, Silvain J, Boulanger B, Cohen M, Goldstein P, Ecollan P, Combes X, Huber K, Pollack C Jr, Bénezet JF, Stibbe O, Filippi E, Teiger E, Cayla G, Elhadad S, Adnet F, Chouihed T, Gallula S, Greffet A, Aout M, Collet JP, Vicaut E; ATOLL Investigators. Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial. Lancet. 2011;378:693-703. doi: 10.1016/S0140-6736(11)60876-3.
52. Rawles JM, Kenmure AC. Controlled trial of oxygen in uncomplicated myocardial infarction. Br Med J. 1976;1:1121-1123.
53. Wilson AT, Channer KS. Hypoxaemia and supplemental oxygen therapy in the frst 24 hours after myocardial infarction: the role of pulse oximetry. J R Coll Physicians Lond. 1997;31:657-661.
54. Kilgannon JH, Jones AE, Shapiro NI, Angelos MG, Milcarek B, Hunter K, Parrillo JE, Trzeciak S; Emergency Medicine Shock Research Network (EMShockNet) Investigators. Association between arterial hyperoxia following resuscitation from cardiac arrest and in-hospital mortality. JAMA. 2010;303:2165-2171. doi: 10.1001/jama.2010.707.
55. Janz DR, Hollenbeck RD, Pollock JS, McPherson JA, Rice TW. Hyperoxia is associated with increased mortality in patients treated with mild therapeutic hypothermia after sudden cardiac arrest. Crit Care Med. 2012;40:3135-3139. doi: 10.1097/CCM.0b013e3182656976.
56. Wang CH, Chang WT, Huang CH, Tsai MS, Yu PH, Wang AY, Chen NC, Chen WJ. The effect of hyperoxia on survival following adult cardiac arrest: a systematic review and meta-analysis of observational studies. Resuscitation. 2014;85:1142-1148. doi: 10.1016/j.resuscitation.2014.05.021.
57. Ukholkina GB, Kostianov IIu, Kuchkina NV, Grendo EP, Gofman IaB. [Effect of oxygenotherapy used in combination with reperfusion in patients with acute myocardial infarction]. Kardiologiia. 2005;45:59.
58. Ranchord AM, Argyle R, Beynon R, Perrin K, Sharma V, Weatherall M, Simmonds M, Heatlie G, Brooks N, Beasley R. High-concentration versus titrated oxygen therapy in ST-elevation myocardial infarction: a pilot randomized controlled trial. Am Heart J. 2012;163:168-175. doi: 10.1016/j. ahj.2011.10.013.
59. Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM; AVOID Investigators. Air Versus Oxygen in ST-Segment-Elevation Myocardial Infarction. Circulation. 2015;131:2143-2150. doi: 10.1161/CIRCULATIONAHA.114.014494.
60. Welsh RC, Travers A, Senaratne M, Williams R, Armstrong PW. Feasibility and applicability of paramedic-based prehospital fbrinolysis in a large North American center. Am Heart J. 2006;152:1007-1014. doi: 10.1016/j.ahj.2006.06.022.
61. Castaigne AD, Hervé C, Duval-Moulin AM, Gaillard M, Dubois-Rande JL, Boesch C, Wolf M, Lellouche D, Jan F, Vernant P. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol. 1989;64:30A-33A; discussion 41A.
62. Schofer J, Büttner J, Geng G, Gutschmidt K, Herden HN, Mathey DG, Moecke HP, Polster P, Raftopoulo A, Sheehan FH. Prehospital thromboly-sis in acute myocardial infarction. Am J Cardiol. 1990;66:1429-1433.
63. Weaver WD, Cerqueira M, Hallstrom AP, Litwin PE, Martin JS, Kudenchuk PJ, Eisenberg M. Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. JAMA. 1993;270:1211-1216.
64. Zeymer U, Arntz HR, Dirks B, Ellinger K, Genzwürker H, Nibbe L, Tebbe U, Senges J, Schneider S; PREMIR-Investigators. Reperfusion rate and inhospital mortality of patients with ST segment elevation myocardial infarction diagnosed already in the prehospital phase: results of the German Prehospital Myocardial Infarction Registry (PREMIR). Resuscitation. 2009;80:402-406. doi: 10.1016/j.resuscitation.2008.12.004.
65. Hartwell D, Colquitt J, Loveman E, Clegg AJ, Brodin H, Waugh N, Royle P, Davidson P, Vale L, MacKenzie L. Clinical effectiveness and cost-effectiveness of immediate angioplasty for acute myocardial infarction: systematic review and economic evaluation. Health Technol Assess. 2005;9:1-99, iii.
66. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, McFadden EP, Dubien PY, Cattan S, Boullenger E, Machecourt J, Lacroute JM, Cassagnes J, Dissait F, Touboul P; Comparison of Angioplasty and Prehospital Thromboysis in Acute Myocardial Infarction study group. Primary angioplasty versus prehospital fbrinolysis in acute myocardial infarction: a randomised study. Lancet. 2002;360:825-829. doi: 10.1016/S0140-6736(02)09963-4.
67. Armstrong PW; WEST Steering Committee. A comparison of pharmaco-logic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study. Eur Heart J. 2006;27:1530-1538. doi: 10.1093/eurheartj/ehl088.
68. Thiele H, Eitel I, Meinberg C, Desch S, Leuschner A, Pfeiffer D, Hartmann A, Lotze U, Strauss W, Schuler G; LIPSIA-STEMI Trial Group. Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angio-plasty in ST-segment myocardial infarction). JACC Cardiovasc Interv. 2011;4:605-614. doi: 10.1016/j.jcin.2011.01.013.
69. Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med. 2013;368:1379-1387. doi: 10.1056/NEJMoa1301092.
70. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial. Lancet. 2006;367:569-578.
71. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, Peruga JZ, Kosmider M, Katz O, Neunteuf T, Jorgova J, Dorobantu M, Grinfeld L, Armstrong P, Brodie BR, Herrmann HC, Montalescot G, Neumann FJ, Effron MB, Barnathan ES, Topol EJ; FINESSE Investigators. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med. 2008;358:2205-2217. doi: 10.1056/NEJMoa0706816.
72. Itoh T, Fukami K, Suzuki T, Kimura T, Kanaya Y, Orii M, Goto I, Matsui H, Sugawara S, Nakajima S, Fusazaki T, Nakamura M; IMPORTANT investigators. Comparison of long-term prognostic evaluation between pre-intervention thrombolysis and primary coronary intervention: a prospective randomized trial: fve-year results of the IMPORTANT study. Circ J. 2010;74:1625-1634.
73. Kurihara H, Matsumoto S, Tamura R, Yachiku K, Nakata A, Nakagawa T, Yoshino T, Matsuyama T. Clinical outcome of percutaneous coronary intervention with antecedent mutant t-PA administration for acute myocar-dial infarction. Am Heart J. 2004;147:E14. doi: 10.1016/j.ahj.2003.10.028.
74. Thiele H, Scholz M, Engelmann L, Storch WH, Hartmann A, Dimmel G, Pfeiffer D, Schuler G; Leipzig Prehospital Fibrinolysis Group. ST-segment recovery and prognosis in patients with ST-elevation myocar-dial infarction reperfused by prehospital combination fbrinolysis, prehos-pital initiated facilitated percutaneous coronary intervention, or primary percutaneous coronary intervention. Am J Cardiol. 2006;98:1132-1139. doi: 10.1016/j.amjcard.2006.05.044.
75. Zijlstra F, Patel A, Jones M, Grines CL, Ellis S, Garcia E, Grinfeld L, Gibbons RJ, Ribeiro EE, Ribichini F, Granger C, Akhras F, Weaver WD, Simes RJ. Clinical characteristics and outcome of patients with early (<2 h), intermediate (4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J. 2002;23:550-557. doi: 10.1053/euhj.2001.2901.
76. Grines CL, Serruys P, O'Neill WW. Fibrinolytic therapy: is it a treatment of the past? Circulation. 2003;107:2538-2542. doi: 10.1161/01. CIR.0000075292.29458.BB.
77. Westerhout CM, Bonnefoy E, Welsh RC, Steg PG, Boutitie F, Armstrong PW. The infuence of time from symptom onset and reperfusion strategy on 1-year survival in ST-elevation myocardial infarction: a pooled analysis of an early fbrinolytic strategy versus primary percutaneous coronary intervention from CAPTIM and WEST. Am Heart J. 2011;161:283-290. doi: 10.1016/j.ahj.2010.10.033.
78. Bonnefoy E, Steg PG, Boutitie F, Dubien PY, Lapostolle F, Roncalli J, Dissait F, Vanzetto G, Leizorowicz A, Kirkorian G, Mercier C, McFadden EP, Touboul P; CAPTIM Investigators. Comparison of primary angio-plasty and pre-hospital fbrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up. Eur Heart J. 2009;30:1598-1606. doi: 10.1093/eurheartj/ehp156.
79. Steg PG, Bonnefoy E, Chabaud S, Lapostolle F, Dubien P Y, Cristofni P, Leizorovicz A, Touboul P; Comparison of Angioplasty and Prehospital Thrombolysis In acute Myocardial infarction (CAPTIM) Investigators. Impact of time to treatment on mortality after prehospital fbrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial. Circulation. 2003;108:2851-2856. doi: 10.1161/01.CIR.0000103122.10021.F2.
80. Widimský P, Budesínský T, Vorác D, Groch L, Zelízko M, Aschermann M, Branny M, St'ásek J, Formánek P; 'PRAGUE' Study Group Investigators. Long distance transport for primary angioplasty vs immediate thromboly-sis in acute myocardial infarction. Final results of the randomized national multicentre trial-PRAGUE-2. Eur Heart J. 2003;24:94-104.
81. Tarantini G, Razzolini R, Napodano M, Bilato C, Ramondo A, Iliceto S. Acceptable reperfusion delay to prefer primary angioplasty over fbrin-specifc thrombolytic therapy is affected (mainly) by the patient's mortality risk: 1 h does not ft all. Eur Heart J. 2010;31:676-683. doi: 10.1093/eurheartj/ehp506.
82. Widimsky P. Primary angioplasty vs. thrombolysis: the end of the controversy? Eur Heart J. 2010;31:634-636. doi: 10.1093/eurheartj/ehp535.
83. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fbrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet. 1994;343:311-322.
84. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999;341:625-634. doi: 10.1056/NEJM199908263410901.
85. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet. 2003;361:13-20. doi: 10.1016/S0140-6736(03)12113-7.
86. Andersen HR, Nielsen TT, Rasmussen K, Thuesen L, Kelbaek H, Thayssen P, Abildgaard U, Pedersen F, Madsen JK, Grande P, Villadsen AB, Krusell LR, Haghfelt T, Lomholt P, Husted SE, Vigholt E, Kjaergard HK, Mortensen LS; DANAMI-2 Investigators. A comparison of coronary angioplasty with fbrinolytic therapy in acute myocardial infarction. N Engl J Med. 2003;349:733-742. doi: 10.1056/NEJMoa025142.
87. Dieker HJ, van Horssen EV, Hersbach FM, Brouwer MA, van Boven AJ, van 't Hof AW, Aengevaeren WR, Verheugt FW, Bär FW. Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS). J Thromb Thrombolysis. 2006;22:39-45. doi: 10.1007/s11239-006-7731-6.
88. Dobrzycki S, Kralisz P, Nowak K, Prokopczuk P, Kochman W, Korecki J, Poniatowski B, Zuk J, Sitniewska E, Bachorzewska-Gajewska H
89. Sienkiewicz J, Musial WJ. Transfer with GP IIb/IIIa inhibitor tirofban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospitals. Eur Heart J. 2007;28:2438-2448. doi: 10.1093/eurheartj/ehm369.
90. Grines CL, Westerhausen DR Jr, Grines LL, Hanlon JT, Logemann TL, Niemela M, Weaver WD, Graham M, Boura J, O'Neill WW, Balestrini C; Air PAMI Study Group. A randomized trial of transfer for primary angio-plasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. J Am Coll Cardiol. 2002;39:1713-1719.
91. Svensson L, Aasa M, Dellborg M, Gibson CM, Kirtane A, Herlitz J, Ohlsson A, Karlsson T, Grip L. Comparison of very early treatment with either fbrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial fow in patients with acute ST-segment elevation myocardial infarction: the Swedish Early Decision (SWEDES) reperfusion trial. Am Heart J. 2006;151:798.e1-798.e7. doi: 10.1016/j.ahj.2005.09.013.
92. Vermeer F, Oude Ophuis AJ, vd Berg EJ, Brunninkhuis LG, Werter CJ, Boehmer AG, Lousberg AH, Dassen WR, Bär FW. Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. Heart. 1999;82:426-431.
93. Widimský P, Groch L, Zelízko M, Aschermann M, Bednár F, Suryapranata H. Multicentre randomized trial comparing transport to primary angio-plasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J. 2000;21:823-831. doi: 10.1053/euhj.1999.1993.
94. Fernández-Avilés F, Alonso JJ, Peña G, Blanco J, Alonso-Briales J, López-Mesa J, Fernández-Vázquez F, Moreu J, Hernández RA, Castro-Beiras A, Gabriel R, Gibson CM, Sánchez PL; GRACIA-2 (Groupo de Análisis de Cardiopatía Isquémica Aguda) Investigators. Primary angioplasty vs. early routine post-fbrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Eur Heart J. 2007;28:949-960. doi: 10.1093/eurheartj/ehl461.
95. Danchin N, Coste P, Ferrières J, Steg PG, Cottin Y, Blanchard D, Belle L, Ritz B, Kirkorian G, Angioi M, Sans P, Charbonnier B, Eltchaninoff H, Guéret P, Khalife K, Asseman P, Puel J, Goldstein P, Cambou JP, Simon T; FAST-MI Investigators. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI). Circulation. 2008;118:268-276. doi: 10.1161/CIRCULATIONAHA.107.762765.
96. Scheller B, Hennen B, Hammer B, Walle J, Hofer C, Hilpert V, Winter H, Nickenig G, Böhm M; SIAM III Study Group. Benefcial effects of immediate stenting after thrombolysis in acute myocardial infarction. J Am Coll Cardiol. 2003;42:634-641.
97. Fernandez-Avilés F, Alonso JJ, Castro-Beiras A, Vázquez N, Blanco J, Alonso-Briales J, López-Mesa J, Fernández-Vazquez F, Calvo I, Martínez-Elbal L, San Román JA, Ramos B; GRACIA (Grupo de Análisis de la Cardiopatía Isquémica Aguda) Group. Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. Lancet. 2004;364:1045-1053. doi: 10.1016/S0140-6736(04)17059-1.
98. Le May MR, Wells GA, Labinaz M, Davies RF, Turek M, Leddy D, Maloney J, McKibbin T, Quinn B, Beanlands RS, Glover C, Marquis JF, O'Brien ER, Williams WL, Higginson LA. Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study). J Am Coll Cardiol. 2005;46:417-424. doi: 10.1016/j.jacc.2005.04.042.
99. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, Lazzam C, Schwartz B, Casanova A, Goodman SG; TRANSFER-AMI Trial Investigators. Routine early angioplasty after fbrinolysis for acute myo-cardial infarction. N Engl J Med. 2009;360:2705-2718. doi: 10.1056/NEJMoa0808276.
100. Bøhmer E, Hoffmann P, Abdelnoor M, Arnesen H, Halvorsen S. Effcacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction). J Am Coll Cardiol. 2010;55:102-110. doi: 10.1016/j.jacc.2009.08.007.
101. Bednár F, Widimský P, Krupicka J, Groch L, Aschermann M, Zelízko M; PRAGUE Study Group Investigators. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocar-dial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). Can J Cardiol. 2003;19:1133-1137.
102. Bagai A, Cantor WJ, Tan M, Tong W, Lamy A, Fitchett D, Cohen EA, Mehta SR, Borgundvaag B, Ducas J, Heffernan M, Davík V, Morrison L, Schwartz B, Lazzam C, Langer A, Goodman SG. Clinical outcomes and cost implications of routine early PCI after fbrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study. Am Heart J. 2013;165:630-637.e2. doi: 10.1016/j.ahj.2012.12.016.
103. Hollenbeck RD, McPherson JA, Mooney MR, Unger BT, Patel NC, McMullan PW Jr, Hsu CH, Seder DB, Kern KB. Early cardiac cath-eterization is associated with improved survival in comatose survivors of cardiac arrest without STEMI. Resuscitation. 2014;85:88-95. doi: 10.1016/j.resuscitation.2013.07.027.
104. Mooney MR, Unger BT, Boland LL, Burke MN, Kebed KY, Graham KJ, Henry TD, Katsiyiannis WT, Satterlee PA, Sendelbach S, Hodges JS, Parham WM. Therapeutic hypothermia after out-of-hospital cardiac arrest: evaluation of a regional system to increase access to cooling. Circulation. 2011;124:206-214. doi: 10.1161/CIRCULATIONAHA.110.986257.
105. Gräsner JT, Meybohm P, Lefering R, Wnent J, Bahr J, Messelken M, Jantzen T, Franz R, Scholz J, Schleppers A, Böttiger BW, Bein B, Fischer M; German Resuscitation Registry Study Group. ROSC after cardiac arrest-the RACA score to predict outcome after out-of-hospital cardiac arrest. Eur Heart J. 2011;32:1649-1656. doi: 10.1093/eurheartj/ehr107.
106. Cronier P, Vignon P, Bouferrache K, Aegerter P, Charron C, Templier F, Castro S, El Mahmoud R, Lory C, Pichon N, Dubourg O, Vieillard-Baron A. Impact of routine percutaneous coronary intervention after out-of-hospital cardiac arrest due to ventricular fbrillation. Crit Care. 2011;15:R122. doi: 10.1186/cc10227.
107. Bulut S, Aengevaeren WR, Luijten HJ, Verheugt FW. Successful out-of-hospital cardiopulmonary resuscitation: what is the optimal in-hospital treatment strategy? Resuscitation. 2000;47:155-161.
108. Bro-Jeppesen J, Kjaergaard J, Wanscher M, Pedersen F, Holmvang L, Lippert FK, Møller JE, Køber L, Hassager C. Emergency coronary an-giography in comatose cardiac arrest patients: do real-life experiences support the guidelines? Eur Heart J Acute Cardiovasc Care. 2012;1:291-301. doi: 10.1177/2048872612465588.
109. Aurore A, Jabre P, Liot P, Margenet A, Lecarpentier E, Combes X. Predictive factors for positive coronary angiography in out-of-hospital cardiac arrest patients. Eur J Emerg Med. 2011;18:73-76. doi: 10.1097/MEJ.0b013e32833d469a.
110. Nanjayya VB, Nayyar V. Immediate coronary angiogram in comatose survivors of out-of-hospital cardiac arrest-an Australian study. Resuscitation. 2012;83:699-704. doi: 10.1016/j.resuscitation.2011.12.004.
111. Reynolds JC, Callaway CW, El Khoudary SR, Moore CG, Alvarez RJ, Rittenberger JC. Coronary angiography predicts improved outcome following cardiac arrest: propensity-adjusted analysis. J Intensive Care Med. 2009;24:179-186. doi: 10.1177/0885066609332725.
112. Strote JA, Maynard C, Olsufka M, Nichol G, Copass MK, Cobb LA, Kim F. Comparison of role of early (less than six hours) to later (more than six hours) or no cardiac catheterization after resuscitation from out-of-hospital cardiac arrest. Am J Cardiol. 2012;109:451-454. doi: 10.1016/j. amjcard.2011.09.036.
113. Tømte O, Andersen GØ, Jacobsen D, Drægni T, Auestad B, Sunde K. Strong and weak aspects of an established post-resuscitation treatment protocol-A fve-year observational study. Resuscitation. 2011;82:1186-1193. doi: 10.1016/j.resuscitation.2011.05.003.
114. Waldo SW, Armstrong EJ, Kulkarni A, Hoffmayer K, Kinlay S, Hsue P, Ganz P, McCabe JM. Comparison of clinical characteristics and outcomes of cardiac arrest survivors having versus not having coronary angiography. Am J Cardiol. 2013;111:1253-1258. doi: 10.1016/j. amjcard.2013.01.267.
115. Nielsen N, Hovdenes J, Nilsson F, Rubertsson S, Stammet P, Sunde K, Valsson F, Wanscher M, Friberg H; Hypothermia Network. Outcome, timing and adverse events in therapeutic hypothermia after out-of-hos-pital cardiac arrest. Acta Anaesthesiol Scand. 2009;53:926-934. doi: 10.1111/j.1399-6576.2009.02021.x.
116. Werling M, Thorén AB, Axelsson C, Herlitz J. Treatment and outcome in post-resuscitation care after out-of-hospital cardiac arrest when a modern therapeutic approach was introduced. Resuscitation. 2007;73:40-45. doi: 10.1016/j.resuscitation.2006.08.018.
117. Zanuttini D, Armellini I, Nucifora G, Carchietti E, Trillò G, Spedicato L, Bernardi G, Proclemer A. Impact of emergency coronary angiogra-phy on in-hospital outcome of unconscious survivors after out-of-hos-pital cardiac arrest. Am J Cardiol. 2012;110:1723-1728. doi: 10.1016/j. amjcard.2012.08.006.
118. Tømte O, Andersen GØ, Jacobsen D, Drægni T, Auestad B, Sunde K. Strong and weak aspects of an established post-resuscitation treatment protocol-A fve-year observational study. Resuscitation. 2011;82:1186-1193. doi: 10.1016/j.resuscitation.2011.05.003.